Recombinant human erythropoietin and blood transfusion in low-birth weight preterm infants under restrictive transfusion guidelines

Saudi Medical Journal

Volumn 27, Issue 6, 2006, Pages 817-820

  Badiee, Zohreh ^a   Pourmirzaiee, Mohmmad A ^a   Kelishadi, Roya ^b   Naseri, Fatemeh ^a  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; IRON; PLACEBO; RECOMBINANT ERYTHROPOIETIN;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG DOSE REGIMEN; ERYTHROCYTE COUNT; ERYTHROCYTE TRANSFUSION; ERYTHROCYTE VOLUME; GESTATIONAL AGE; HEMATOCRIT; HUMAN; HUMAN CELL; INFANT; IRAN; LEUKOPENIA; LOW BIRTH WEIGHT; MAJOR CLINICAL STUDY; NEWBORN ANEMIA; NEWBORN INTENSIVE CARE; PRACTICE GUIDELINE; PREMATURITY; RANDOMIZED CONTROLLED TRIAL; RETICULOCYTE COUNT; SINGLE BLIND PROCEDURE; THROMBOCYTOPENIA;

ERYTHROCYTE TRANSFUSION; ERYTHROPOIETIN, RECOMBINANT; HEMATOCRIT; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, VERY LOW BIRTH WEIGHT; IRAN; LEUKOPENIA; PRACTICE GUIDELINES; PRACTICE GUIDELINES AS TOPIC; THROMBOCYTOPENIA;

EID: 33746428393     PISSN: 03795284     EISSN: 03795284     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Bechensteen AG, Haga P, Halvorsen S, Whiterlaw A, Liestol K, Lindermann R, et al. Erythropoietin, protein, and iron supplementation and the prevention of anemia of prematurity. Arch Dis Child 1993; 69: 19-23.
2. Beck D, Masserey E, Meyer M, Calame A. Weekly intravenous administration of recombinant human erythropoietin in infants with the anemia of prematurity. Eur J Pediatr 1991; 150: 767-772.
3. Shannon KM, Mentzer WC, Ables RI, Freeman P, Newton N, Thompson D, et al. Recombinant human erythropoietin in the anemia of prematurity: results of a placebo-controlled pilot study. J Pediatr 1991; 118: 949-955.
4. Strauss RG. Neonatal anemia: Pathophysiology and treatment. Immunological Investigation 1995; 24: 341-351.
5. Attias D. Pathophysiology and Treatment of the anemia of prematurity. Journal of Pediatric Hematology/Oncology 1991; 13: 13-18.
6. Halperin DS, Felix M, Wacker P, Lacourt G, Babel JF, Wyss M. Recombinant human erythropoietin in the treatment of infants with anemia of prematurity. Eur J Pediatr 1992; 151: 661-667.
7. Soubasi V, Kremenopoulos G, Diamandi E,T Santali C, Tsakiris D. In which neonates does early recombinant human erythropoietin treatment prevent anemia of prematurity? Results of a randomized controlled study. Ped Res 1993; 34: 675-679.
8. Widness JA, Seward VJ, Kromerr IJ, Burmeister LF, Bell EF, Strauss RG. Changing patterns of red blood cell transfusion in very low birth weight infants. J Pediatr 1996; 129: 680-687.
9. Vamvakas FC, Strauss RG. Meta-analysis of controlled clinical trials studying the efficacy of r-HuEPo in reducing blood transfusions in the anemia of prematurity. Transfusion 2001; 42: 406-415.
10. Bifano EM, Curran TR. Minimizing donor blood exposure in the neonatal intensive care unit. Current trends and future prospects. Clin Perinatol 1995; 22: 657-669.
11. Asch J, Wedgood JF. Optimizing the approach to anemia in the preterm infant: Is there a role for erythropoietin therapy? J Perinatol 1997; 17: 276-282.
12. Hesse L, Eberl W, Schlaud M, Poets CF. Blood Transfusion: Iron load and retinopathy of Prematurity. Eur J Pediatr 1997; 156: 465-470.
13. Inder TE, Clemeett RS, Austin NC, Graham P, Darlow BA. High iron status in very low birth weight infants is associated with an increased risk of retinopathy of prematurity. J Pediatr 1997; 131: 541-544.
14. Silvers KM, Gibson AT, Russell JM, power HJ. Antioxidant activity, packed cell transfusions, and outcome in premature infants. Arch Dis Child 1998; 78: 214-219.
15. Cooke RW, Drury JA, Yoxall CW, James C. Blood transfusion and chronic lung disease in preterm infants. Eur J Pediatr 1997; 156: 47-50.
16. Maier RF, Obladen M, Muller-Hansen I, Kattner E, Merz U, Arlettaz R, et al. Early treatment with erythropoietin beta ameliorates anemia and reduces transfusion requirements in infants with birth weights below 1000g. J Pediatr 2002; 141: 8-15.
17. Rocha VL, Benjamin AC, Procianoy RS. The effect of recombinant human erythropoietin on the treatment of anemia of prematurity. Journal de Pediatria 2001; 77: 76-83.
18. Maier RF, obladen M, scigalla P, Lindercamp O, Duc G, Hieronimi G, et al. The effect of epoetin beta (recombinant human erythropoietin) on the need for transfusion in very low birth weight infants. N Engl J Med 1994; 330: 1173-1178.
19. Arif B, Ferhan K. Recombinant human erythropoietin therapy in low-birth weight preterm infants: A prospective controlled study. Pediatrics International 2005; 74: 67-71.
20. Ohls RK. Erythropoietin treatment in extremely low birth weight infants: blood in versus blood out. J Pediat 2002; 141: 3-6.
21. Franz AR, Pohlandt F. Red blood cell transfusions in very and extremely lowbirth weight infants under restrictive transfusion guidelines: is exogenous erythropoietin necessary? Arch Dis Child Fetal Neonatal 2001; 84: 96-100.
22. Meyer MP, Sharma E, Carsons M. Recombinant erythropoietin and blood transfusion in selected preterm infants. Arch Dis Child Fetal Neonatal Ed 2003; 88: 41-45
23. Meyer MP, Meyer JH, Commerford A, Hann FM, Sive AA, Moller G, et al. A. Recombinant human erythropoietin in the treatment of the anemia of prematurity: results of a double-blind, placebo controlled study. Pediatrics 1994; 93: 918-923.
24. Reiter PD, Rosenberg AA, Valuck R, Novak K. Effect of short-term erythropoietin therapy in anemic premature infants. J Perinatol 2005; 25: 125-129.
25. Turker G, Sarper N, Gokalp AS, Usluer H. The effect of early recombinant erythropoietin and enteral iron supplementation on blood transfusion in preterm infants. Am J Perinatol 2005; 22: 449-455.
26. Ohls RK, Ehrenkranz RA, Wright LL, Lemons JA, Korones SB, Stoll BJ, et al. Effects of early erythropoietin therapy on the transfusion requirements of preterm infants below 1250 grams birth weight: a multicenter, randomized, controlled trial. Pediatrics 2001; 108: 934-942.
27. Christensen RD, Hunter DD, Ohls RK. Pilot study comparing recombinant erythropoietin alone with erythropoietin plus recombinant granulocyte-macrophage colony stimulating factor for treatment Of the anemia of prematurity. J Perinatol 1994; 14: 110-113.